Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Kaia Health raises $75m to develop motion tracking solution

Europe's most funded digital therapeutics start-up Kaia Health has raised a $75m Series C bringing its total amount raised to date to over $100m. CEO Konstantin Mehl tells HBI it will be spent on building the commercial team in Germany and the States as well as developing its motion detection solution used for treating chronic pain on mobile phones.

Ramsay Santé borrows €1.65bn dirt cheap

Ramsay Santé, the European arm of global hospital group Ramsay Health Care, has refinanced its €1.65bn syndicated debt and introduced an environmental, social and governance (ESG) component for the first time. The interest rate is eye-wateringly low for an S&P BB- rated issue, reflecting the backing that Ramsay Santé enjoys from the French government.

India’s Covid crisis to peak ‘for another two weeks’

Indian hospitals are struggling and failing to cope with the ruinous COVID-19 wave running rife through the country. As resources dwindle and the international community steps up efforts to assist, HBI talks to an exhausted Delhi-based for-profit hospital operator source who is on the frontlines. He says their modelling predicts another two weeks of intense pressure.

UK infra investors buy 650 retirement homes for £200m

A new joint venture between investment groups John Laing and Macquarie has agreed to acquire 650 retirement home properties from the country's biggest retirement home developer & operator McCarthy & Stone, for a total of £200m (€230m). 

Bridgepoint’s IDH buy could signal pan-European ambitions

Bridgepoint has been confirmed as the buyer for the UK's largest dental group IDH/mydentist, which is to be sold on a 10x EBITDA multiple. The private equity firm already owns a Norwegian dental asset and others are coming to market in the next 12 months, so the deal could see the emergence of another pan-European dental group. But it is a poor outcome for current holders Carlyle and Palamon.

Synlab IPO priced low

Lab group Synlab has announced pricing at the bottom of its range, a price that values the group at just 8.8 times 2020 EBITDA. Sources say that investors are worried about the resilience and performance of its huge COVID earnings. The IPO is now proceeding at a valuation far lower than that generated by the sale of Cerba to EQT.

Interview: Raj Shah, Partner and Head of Healthcare, Nordic Capital

Few investors have been as active in healthcare services as Nordic Capital. Or as ambitious in building pan-European platforms in outpatient sectors such as dentistry, veterinary and ophthalmology. Raj Shah is also looking for new deals - Nordic has just raised a massive €6.1bn for its tenth fund of which 30-40% is destined for healthcare. 

Eurofins wins €48m contract for EU-wide genome sequencing

The European Centre for Disease Prevention and Control has awarded Eurofins a €48m whole-genome sequencing (WGS) contract for COVID-19 variant testing. The move demonstrates confidence that countries will be running high volumes of COVID-19 testing in the mid to long term.

Unilabs enters Peruvian imaging

Diagnostic group Unilabs has entered Peruvian imaging with the acquisition of Cimedic. The group says it's the start of a strategic plan for diagnostic growth in the country.

Find Us